# FORAY bioscience

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/foray-bioscience

- Industry: Biotechnology
- Headquarters: Cambridge, US
- Website: www.foraybio.com
- Total disclosed funding: $3.4M
- Latest round: Seed (Feb 28, 2024)
- Investors on record: 5

## About

Based in Massachusetts, US, and founded in 2022 by Ashley Beckwith, FORAY Bioscience, Inc., a.k.a. Foray Bioscience operates as a biotechnology company that focuses on biomanufacturing tree and plant products for supply and to prevent deforestation. In February 2024, FORAY Bioscience, Inc. raised USD 3.41 million in venture funding. The round was part of a larger USD 3.91 million venture fund.

Foray is developing a platform to bioengineer an expansive range of plant-based products by combining plant cell culture, materials science, and tissue engineering to provide sustainable alternatives to traditional wood products and help prevent deforestation.

## Funding rounds

- Seed, Feb 28, 2024, $3.4M — Engine Ventures, Susquehanna Private Capital, ReGen Ventures, Understorey Ventures, Superorganism

## Investors

- Engine Ventures (https://capitalatlas.ai/funds/engine-ventures) — Seed
- Susquehanna Private Capital — Seed
- ReGen Ventures (https://capitalatlas.ai/funds/regen-ventures) — Seed
- Understorey Ventures — Seed
- Superorganism (https://capitalatlas.ai/funds/superorganism) — Seed